✦ LIBER ✦

PET concerns in bevacizumab treatment

✍ Scribed by Goessl, Carsten; Grozdanovic, Zarko

Book ID: 109928743
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 246 KB
Volume: 10
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm0604-561a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to “PET concerns in bevacizumab tr

Reply to “PET concerns in bevacizumab treatment”

✍ Willett, Christopher G; Duda, Daniel; Fischman, Alan; Jain, Rakesh K 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

Hearty concerns for bevacizumab in breas

Hearty concerns for bevacizumab in breast cancer lifted?

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Bevacizumab treatment in hereditary hemo

Bevacizumab treatment in hereditary hemorrhagic teleangiectasia

✍ Sebastian Föllner, Michael Ibe, Jens Schreiber 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 78 KB

PET/CT in paediatric oncology: clinical

PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns

✍ Giovanni Lucignani; Diego De Palma 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 120 KB

Bevacizumab in the treatment of breast c

Bevacizumab in the treatment of breast cancer

✍ Angelos K. Koutras; George Fountzilas; Thomas Makatsoris; Stavros Peroukides; Ha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Bevacizumab in the Treatment of Ovarian

Bevacizumab in the Treatment of Ovarian Cancer

✍ Florian Heitz, Philipp Harter, Jana Barinoff, Bianca Beutel, Paevi Kannisto, Jac 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 963 KB